These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 758813)

  • 1. Use of bethanechol chloride with phenothiazines: a case report.
    Schubert DS
    Am J Psychiatry; 1979 Jan; 136(1):110-1. PubMed ID: 758813
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
    Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
    J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol, benztropine, fluphenazine decanoate, and delirium.
    Lima BR; Vanneman D
    Am J Psychiatry; 1983 May; 140(5):659-60. PubMed ID: 6846615
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
    Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
    Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract]   [Full Text] [Related]  

  • 6. Rigidity, hyperpyrexia and coma following fluphenazine enanthate.
    Meltzer HY
    Psychopharmacologia; 1973; 29(4):337-46. PubMed ID: 4707025
    [No Abstract]   [Full Text] [Related]  

  • 7. Benztropine prophylaxis of dystonic reactions.
    Stern TA; Anderson WH
    Psychopharmacology (Berl); 1979 Mar; 61(3):261-2. PubMed ID: 36644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
    Siris SG; Rifkin A; Reardon GT; November M
    Am J Psychiatry; 1983 Aug; 140(8):1069-71. PubMed ID: 6346910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
    Swett C; Cole JO; Shapiro S; Slone D
    Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of vomiting related to the interactions of antipsychotics and benztropine.
    Schaffer CB; Shahid A; Javaid JI; Davis JM
    Am J Psychiatry; 1981 Jun; 138(6):833-5. PubMed ID: 6113771
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics.
    Winslow RS; Stillner V; Coons DJ; Robison MW
    Am J Psychiatry; 1986 Jun; 143(6):706-10. PubMed ID: 2872822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis of rapid abnormal involuntary movements associated with fluphenazine decanoate.
    Glazer WM; Moore DC
    J Nerv Ment Dis; 1980 Jul; 168(7):439-41. PubMed ID: 7400795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract]   [Full Text] [Related]  

  • 14. Protracted vomiting following abrupt cessation of psychotropics: a case report.
    Kalman T; Warner GM
    Can Psychiatr Assoc J; 1978 Apr; 23(3):163-5. PubMed ID: 647615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
    Stenson RL; Donion PT; Meyer JE
    Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted treatment of depression-like symptoms in schizophrenia.
    Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Fasano-Dube B
    Psychopharmacol Bull; 1987; 23(1):85-9. PubMed ID: 3602335
    [No Abstract]   [Full Text] [Related]  

  • 17. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP; McCue M; Freter S
    Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of bed-wetting with benztropine.
    Costa JF; Sramek J; Bera RB; Brenneman M; Cristobal M
    Am J Psychiatry; 1990 May; 147(5):674. PubMed ID: 2327502
    [No Abstract]   [Full Text] [Related]  

  • 19. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Schooler NR; Levine J
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparkinson drugs as causal agents in tardive dyskinesia.
    Kiloh LG; Smith JS; Williams SE
    Med J Aust; 1973 Sep; 2(12):591-3. PubMed ID: 4149942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.